I. Medical Technical Options Committee
1. Helen Tope, co-chair of the Medical Technical Options Committee, presented the Committee’s assessment of additional information provided in relation to the essential use nomination for chlorofluoroc...
ARTICLE 1: AMENDMENT
A. Article 4, paragraph 1 qua.
The following paragraph shall be inserted after paragraph 1 ter of Article 4 of the Protocol:
1 qua. Within one year of the dat...
TRUST FUND FOR THE MONTREAL PROTOCOL ON SUBSTANCES THAT DEPLETE THE OZONE LAYER: APPROVED 1993, REVISED 1994 AND APPROVED 1995 BUDGETS FOR THE OZONE SECRETARIAT
10 PROJECT PERSONNEL COMPONENT (a)
w/m 1993 w/m 1994 w/m 1995
1100 P...
BASED ON THE UNITED NATIONS
SCALE OF ASSESSMENT (GENERAL ASSEMBLY RESOLUTION 55/5B-F OF 23 DECEMBER 2000)
WITH NO PARTY PAYING MORE THAN 22 PER CENT
(inUnited States dollars)